During the last years, there is an increase of field knowledge on a number of comorbidities and extra-articular manifestations (EAMs) associated with inflammatory arthritis. Many adults suffering from inflammatory arthritis also have other chronic conditions, so early detection is key to a patient’s quality of life and survivability outcomes. Comorbidities and Extra-articular Manifestations in Inflammatory Arthritis, the 18th volume in Elsevier’s Handbook for Systemic Autoimmune Diseases series, provides a comprehensive review of the latest research on various comorbidities and EAMs associated with inflammatory arthritis.
The book chapters review comorbidities and extra-articular manifestations in early and late disease stages, mechanisms involved in comorbidities development, as well as the impact of new treatment strategies specific to inflammatory arthritis and cardiovascular disease, metabolic syndrome, metabolic bone, infection, neoplasia, respiratory, gastrointestinal, kidney, mental health disease, and neurological disease. This book serves as an ideal reference for researchers and clinicians focused on inflammatory arthritis and related diseases.
1. Introduction to comorbidities, extra-articular and
extra-musculoskeletal manifestations
2. Cardiovascular disease and rheumatoid arthritis
3. Cardiovascular disease and spondyloarthritis
4. Cardiovascular disease and psoriatic arthritis
5. Metabolic syndrome and psoriatic arthritis
6. Bone involvement in rheumatoid arthritis, spondyloarthritis and psoriatic
arthritis
7. Infection and rheumatoid arthritis, spondyloarthritis and psoriatic
arthritis
8. Pulmonary manifestations in rheumatoid arthritis
9. Gastrointestinal involvement in spondyloarthritis
10. Mental health disorders in rheumatoid arthritis, spondyloarthritis and
psoriatic arthritis
11. Alzheimers disease and rheumatoid arthritis
Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects. Elena Nikiphorou, MD, PhD, is an Adjunct Senior Lecturer at Kings College London and Consultant Rheumatologist at Kings College Hospital in London, United Kingdom. She has a clinical and academic interest in inflammatory arthritis and the role of multi-morbidity and long-term outcomes of disease. She has been the recipient of multiple awards, bursaries, and competitive roles, and has held key leadership positions at national and international levels.
